Diazepam binding inhibitor (DBI), an endogenous 10-kDa polypeptide was isolated from rat and human brain by monitoring displacement of radioactive diazepam bound to specific recognition sites in brain synaptic and mitochondrial membranes. The cellular location ofDBI mRNA was studied in rat brain and selected peripheral tissues by in situ hybridization histochemistry with a 35S-labeled singlestranded complementary RNA probe. DBI mRNA was heterogeneously distributed in rat brain, with particularly high levels in the area postrema, the cerebellar cortex, and ependyma ofthe third ventricle. Intermediate levels were found in the olfactory bulb, pontine nuclei, inferior colliculi, arcuate nucleus, and pineal gland. Relatively low but significant levels of silver grains were observed overlying many mesencephalic and telencephalic areas that have previously been shown to contain numerous DBI-immunoreactive neurons and a high
density of central benzodiazepine receptors. In situ hybridizations also revealed high levels of DBI mRNA in the posterior lobe of the pituitary gland, liver, and germinal center of the white pulp of spleen, all tissues that are rich in peripheral benzodiazepine binding sites. The tissue-specific pattern ofDBI gene expression described here could be exploited to further understand the physiological function of DBI in the brain and periphery.
Diazepam binding inhibitor (DBI) (1), also called endozepine (2) , is an endogenous 10-kDa polypeptide that was initially purified from mammalian brain based on its ability to displace specific ligands from benzodiazepine recognition sites on y--aminobutyric acid (GABAA) receptors (1, 2) and on mitochondrial membranes (3, 4) . The amino acid sequence of DBI has been determined by chemical and complementary DNA (cDNA) analysis for rat (1, 5, 6) , human (7) (8) (9) (10) , porcine (11) , and bovine (9, 10) brain.
Rat brain DBI displaces P-carboline derivatives (K;, -5
,uM) from their specific recognition sites on brain synaptic membranes (1, 2) . Recording of GABA-regulated Cl-currents in the whole-cell mode indicates that DBI is a negative allosteric modulator of GABAA receptors (12, 13) ; this finding is consistent with the proconflict action elicited by nanomolar amounts of DBI injected intraventricularly into rats (6) . Immunohistochemical studies of the location of DBI immunoreactivity in rat brain structures indicate that it is localized in selected neuronal and glial cell populations (14) .
DBI preferentially colocalizes with GABA in GABAergic neurons (15) and it can be co-released with GABA from primary cultures of cortical neurons after veratridine-or high-potassium-induced depolarization (16) .
The tryptic digestion of DBI yields an octadecaneuropeptide (ODN), which shares with DBI some biological properties (6) . Immunoreactivity to antibodies directed against ODN can be detected immunohistochemically in neurons exclusively, and not in glial cells where, however, DBI-like immunoreactivity can be featured (17, **). ODN (DBI 33-50) and the ODN-like peptides icosapentaneuropeptide and triakontatetraneuropeptide (DBI 17-50) have been isolated and sequenced from homogenates of rat brain (4) . Since these compounds cannot be detected in primary cultures of glial cells (16) , they might be specific neuronal processing products of DBI. These data suggest a precursor role of DBI for a group of biologically active neuropeptides that may act as putative allosteric modulators of signal transduction at GABAergic synapses containing different subtypes of GABAA receptors. Subsequently, DBI mRNA and immunoreactivity have also been detected in a wide variety of peripheral tissues (5, 7, 10) . Specifically, high levels of DBI mRNA were observed in liver, adrenal gland, testis, heart, and kidney (5, 7, 10) , while lower levels were observed in lung and muscle. High density ofbenzodiazepine binding sites has also been observed in peripheral tissues (18) (19) (20) , and the density ofthese sites bears a relationship with the concentration of DBI (4) . To identify the sites of DBI biosynthesis in the central nervous system and in selected peripheral tissues, we have used in situ hybridization with a "S-labeled single-stranded RNA probe complementary to DBI mRNA.
MATERIALS AND METHODS
Preparation of Probes. A 442-base-pair EcoRI/Rsa I fragment from pIMc6l containing the complete coding region and most of the 3' untranslated region of the rat DBI cDNA (5) was subcloned between the unique EcoRI (10-15 ,um) were cut with a Hacker cryostat microtome, thawmounted onto gelatin and poly-L-lysine-coated glass microscope slides, and stored at -70'C until time of use.
In Situ Hybridization Procedure. The sections were thawed at room temperature and treated with proteinase K (Sigma; 5 Ag/ml) in diethyl pyrocarbonate (DEPC)-treated deionized distilled H20 for 10 min at room temperature to partially deproteinize the tissue. The sections were rinsed in 2 x SSC (1 x SSC = 0.15 M sodium chloride/0.015 M sodium citrate, pH 7). The tissue sections were then covered with a prehybridization solution [50% formamide/0.6 M NaCl/10 mM Tris HCl, pH 7.5/0.02% Ficoll/0.02% polyvinylpyrrolidone/ 0.1% bovine serum albumin/1 mM EDTA/salmon sperm DNA (50 ,ug/ml)/yeast total RNA(500 ,g/ml)/yeast transfer RNA (50 ,g/ml)] and prehybridized for 60-120 min at 50°C. After prehybridization, the buffer was removed, and the tissue sections were covered with hybridization solution [50% formamide/0.6 M NaCl/10 mM Tris HCI, pH 7.5/0.02% Ficoll/0.02% polyvinylpyrrolidone/0.1% bovine serum albumin/1 mM EDTA/salmon sperm DNA (10 ,ug/ml)/yeast total RNA (50 ,ug/ml)/yeast transfer RNA (50 ,ug/ml)] containing 2.5 x 106 cpm/ml of 35S-labeled DBI sense or antisense single-stranded RNA probes that had been heated and denatured for 10-15 min at 65°C. The sections were hybridized for 16-18 hr at 50°C in boxes humidified with 50% formamide and 4 x SSC.
After hybridization, the sections were washed in 3 liters of 2 x SSC at 45°C for 30 min and subjected to RNase A digestion (30 ,g/ml in 500 mM NaCl/10 mM Tris-HCl, pH 7.5) for 60 min at 37°C. The To test the specificity of hybridization in each brain area, identically treated serial sections were hybridized with the "S-labeled antisense DBI probe and with the "S-labeled sense DBI probe (control) or with a pro-opiomelanocortin probe.
RESULTS
In situ hybridization revealed that DBI mRNA was heterogeneously distributed in rat brain, pituitary, and spleen. In liver, the DBI mRNA was uniformly distributed throughout the tissue. Two kinds of controls were used to establish the specificity of the in situ hybridization data obtained in these studies. First, each section that was hybridized with an antisense "S-labeled DBI complementary RNA (cRNA) probe was paired with an identically treated section that was hybridized with the sense-strand "S-labeled DBI control probe. The sense strand used resulted in uniform randomly distributed background levels of silver grains. Hybridization of serial sections with "'S-labeled pro-opiomelanocortin cRNA failed to specifically label areas that were labeled by the 35S-labeled DBI probe, such as the area postrema.
Particularly high levels of DBI mRNA signal were observed in cerebellum, ependyma of third ventricle, and the area postrema, while a less dense signal was noted in the pontine nuclei, inferior colliculi, arcuate nucleus of the hypothalamus, pineal gland, and olfactory bulb, and low but higher than background levels of signal were seen in all brain areas when compared to identical sections hybridized with sense-strand control probe (Fig. 1) .
At the cellular level, hybridization of brainstem sections with antisense 35S-labeled DBI cRNA revealed a dense autoradiographic labeling over the cells in the area postrema ( Fig. 2A) (Fig. 3A) .
Purkinje cells were not labeled. Also a high density of silver grains in the molecular layer, possibly overlying the basket and stellate neurons or glial cells of the cerebellar cortex was detected. Only a few silver grains were observed over the granular layer and white matter of the cerebellar cortex (Fig.  3A) . When cerebellar tissue sections were hybridized with the control probe, only background levels of silver grains were observed (Fig. 3B) . Many mesencephalic and telencephalic areas such as cortex, hippocampus, and some thalamic nuclei revealed a low but above background density of silver grains when compared to sense RNA controls after DBI cRNA hybridization (Fig. 3C) . Some nonneuronal structures around the third ventricle (ependyma, tanycytes, and the subfornical organ) revealed a high density of silver grains after DBI mRNA hybridization (Fig. 3D) . When serial sections of these areas were hybridized with the control probe, no specific labeling was observed.
Hybridization ofthe rat pituitary with antisense "S-labeled DBI cRNA revealed a high level of silver grains overlying the posterior lobe (Fig. 4A) , with only low levels of silver grains overlying the anterior and intermediate lobes.
Hybridization of liver sections with antisense "S-labeled DBI cRNA revealed a uniform autoradiographic labeling overlying all cells of this tissue (Fig. 4B) . Hybridization of spleen sections with antisense "S-labeled DBI cRNA revealed specific labeling overlying the germinal center of the white pulp, with lower levels of silver grains overlying the surrounding red pulp (data not shown). DISCUSSION
We have investigated the distribution of DBI mRNA in the rat brain and selected peripheral tissues by a sensitive and specific in situ hybridization method. Our results indicate that DBI mRNA is heterogeneously distributed in the rat brain, pituitary, and spleen. Particularly high levels of DBI mRNA were observed in the area postrema, the cerebellar cortex and ependyma of the third ventricle. However, after 2-to 4-week exposures with high specific activity "S-labeled DBI cRNA probes, much lower levels of silver grains were observed overlying many mesencephalic and telencephalic areas such as cortex, hippocampus, and hypothalamic areas. These areas have previously been shown to contain numerous DBI immunoreactive neurons and DBI-LI (14, 21, **). It is possible that the DBI-ODN in the cells of these areas has a slow turnover, which could be maintained by a low content of DBI mRNA. However, these areas are believed to be the sites effective in the anxiolytic and anticonvulsant actions of the benzodiazepines (1, 3, 14) . In fact, the highest densities of central benzodiazepine recognition sites are found in the cerebal 7020 Neurobiology: Alho et al. formation; DG, dentate gyrus. (D) In the hypothalamic area the highest density of silver grains was observed in the ependyma and tanycytes of the third ventricle (3V), the nucleus arcuate (Arc), and the median eminence (ME). When serial sections were hybridized with a sense strand (control) probe, no specific labeling was observed in these areas, indicating that the antisense labeling was not a result of an edge artifact. (Bars = 20 pm). cortex and limbic structures, including the hippocampus (22, 23) . Previously, DBI mRNA and DBI immunoreactive polypeptides have been detected in numerous peripheral tissues including testis, heart, kidney, liver, lung, intestine, and adrenals (2, 5, 7, 10, 11) . The present in situ hybridization studies confirm that DBI mRNA is located in liver and spleen cells. Peripheral benzodiazepine receptors have been identified based on their high affinity for 3H-labeled RO-54864, a benzodiazepine devoid of anxiolytic activity (24, 25) . Peripheral benzodiazepine receptors have been detected in heart, lung, kidney, adrenals, pituitary, testis, liver, spleen, and in selected areas of the brain (18) (19) (20) . The peripheral-type benzodiazepine receptor in rat adrenal gland has been localized to the mitochondrial outer membrane by the subcellular fractionation studies of Anholt et al. (25) . The physiological function of the mitochondrial recognition site of peripheraltype benzodiazepines is unclear. However, numerous metabolic effects of peripheral-type benzodiazepines have been reported. These include (i) an enhanced melanogenesis in melanoma cells, (ii) an induction of hemoglobin synthesis in Friend erythroleukemia cells, (iii) an inhibition of proliferation of thymoma cells, and (iv) a stimulation of phospholipid methylation in C6 astrocytoma cells (26) (27) (28) (29) .
It has been recently reported that DBI purified from rat brain displaces the peripheral benzodiazepine receptor ligands 3H-labeled PK11194 or 3H-labeled RO-54864 from mitochondria prepared from rat adrenal gland cortex or from rat astrocytes in primary cultures prepared from rat cerebral cortex (K-5 AM) (15, 30) . These data raise the possibility that DBI may interact physiologically with the peripheral benzodiazepine regulation site and elicit an as yet undefined biological activity.
Previous DNA blot analysis of rat and human genomic DNA has suggested that DBI is encoded by a multigene family of at least five members (7 
